ℹ️
🇬🇧
Search
Search for publications relevant for "Reparixin"
Reparixin
Publication
Class
Person
Publication
Programmes
Export current view
publication
A randomized, placebo-controlled phase 2 study of paclitaxel in combination with reparixin compared to paclitaxel alone as front-line therapy for metastatic triple-negative breast cancer (fRida)
2021 |
Publication without faculty affiliation
